Anti-Tumor Necrosis Factor Alpha Therapeutic Drug Monitoring in Inflammatory Disease: A Systematic Review

CONCLUSION: TDM of anti-TNF-α biologics in IBD has demonstrated success through RCTs. Knowledge gained from these studies applies to dermatologic treatment. J Drugs Dermatol. 2023;22(5): doi:10.36849/JDD.6671.PMID:37133467 | DOI:10.36849/JDD.6671

Source: Journal of Drugs in Dermatology - May 3, 2023 Category: Dermatology Authors: Caralin Schneider Scott Stratman Siri Choragudi Hadar Lev-Tov Source Type: research